Abstract
Lung protection is a cutting-edge topic for cardiovascular surgeons; for several decades the main concern has been just to protect the heart by preventing ischemia-reperfusion injury [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sievers HH, Freund-Kaas C, Eleftheriadis S, Fischer T, Kuppe T, Kraatz EG, et al. Lung protection during total cardiopulmonary bypass by isolated lung perfusion: preliminary results of a novel perfusion strategy. Ann Thorac Surg. 2002;74:1167–72.
Farivar AS, Delgado MF, McCourtie AS, Barnes AD, Verrier ED, Mulligan MS. Crosstalk between thrombosis and inflammation in lung reperfusion injury. Ann Thorac Surg. 2006;81:1061–7.
Zhang L, Kumar S, Kaminski A, Kasch C, Sponholz C, Stamm C, et al. Importance of endothelial nitric oxide synthase for the hypothermic protection of lungs against ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2006;131:969–74.
Iglesias M, Jungebluth P, Petit C, Matute MP, Rovira I, Martínez E, et al. Extracorporeal lung membrane provides better lung protection than conventional treatment for severe postpneumonectomy noncardiogenic acute respiratory distress syndrome. J Thorac Cardiovasc Surg. 2008;135:1362–71.
Gazoni LM, Walters DM, Unger EB, Linden J, Kron IL, Laubach VE. Activation of A1, A2A, or A3 adenosine receptors attenuates lungischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2010;140:440–6.
Krishnadasan B, Naidu BV, Byrne K, Fraga C, Verrier ED, Mulligan MS. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2003;125:261–72.
Naidu BV, Woolley SM, Farivar AS, Thomas R, Fraga CH, Goss CH, et al. Early tumor necrosis factor-α release from the pulmonary macrophage in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2004;127:1502–8.
Anvari F, Sharma AK, Fernandez LG, Hranjec T, Ravid K, Kron IL, et al. Tissue-derived proinflammatory effect of adenosine A2B receptor inlung ischemia – reperfusion injury. J Thorac Cardiovasc Surg. 2010;140:871–7.
Carvalho EMF, Gabriel EA, Salerno TA. Pulmonary protection during cardiac surgery: systematic literature review. Asian Cardiovasc Thorac Ann. 2008;16:503–7.
Murakami K, Okajima K, Uchiba M, Johno M, Nakagaki T, Okabe H, et al. Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol. 1997;272:L197–202.
Lisle TC, Gazoni LM, Fernandez LG, Sharma AK, Bellizzi AM, Schifflett GD, et al. Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A2A receptor activation. J Thorac Cardiovasc Surg. 2008;136:1280–8.
Yamazaki S, Inamori S, Nakatani T, Suga M. Activated protein C attenuates cardiopulmonary bypass-induced acutelung injury through the regulation of neutrophil activation. J Thorac Cardiovasc Surg. 2011;141:1246–52.
Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, et al. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol. 2000;164:436–42.
Emaminia A, LaPar DJ, Zhao Y, Steidle JF, Harris DA, Laubach VE, et al. Adenosine A2A agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg. 2011;92:1840–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Gabriel, E.A., Gabriel, S.A. (2013). Lung Protection in Cardiovascular Surgery. In: Gabriel, E., Gabriel, S. (eds) Inflammatory Response in Cardiovascular Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4429-8_33
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4429-8_33
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4428-1
Online ISBN: 978-1-4471-4429-8
eBook Packages: MedicineMedicine (R0)